OmniAb (OABI) Common Equity (2021 - 2026)
OmniAb (OABI) reported Common Equity of $262.6 million for Q1 2026, down 3.97% year-over-year from $273.5 million in Q1 2025, and down 1.64% quarter-over-quarter from $267.0 million in Q4 2025.
OmniAb (OABI) Common Equity (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Common Equity data on file, last reported at $262.6 million in Q1 2026.
- Common Equity for Q1 2026 came in at $262.6 million, down 3.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $262.6 million (down 3.97% YoY), and the FY2025 annual result was $267.0 million, down 7.16% from the prior year.
- Common Equity retreated to $262.6 million in Q1 2026 per OABI's latest filing, from $267.0 million in the prior quarter.
- Over five years, Common Equity peaked at $341.4 million in Q4 2022 and troughed at $224.9 million in Q1 2022.
- A 5-year average of $285.7 million and a median of $287.6 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2024: Common Equity soared 1509933.93% in 2022, then dropped 11.87% in 2024.
- A 5-year view of Common Equity shows it stood at $341.4 million in 2022, then slipped by 7.85% to $314.6 million in 2023, then fell by 8.57% to $287.6 million in 2024, then slipped by 7.16% to $267.0 million in 2025, then retreated by 1.64% to $262.6 million in 2026.
- Business Quant data shows OABI's Common Equity at $262.6 million in Q1 2026, $267.0 million in Q4 2025, and $277.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 262.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262.65 Mn |
| Dec 31, 2025 | 267.03 Mn |
| Sep 30, 2025 | 277.44 Mn |
| Jun 30, 2025 | 262.06 Mn |
| Mar 31, 2025 | 273.52 Mn |
| Dec 31, 2024 | 287.62 Mn |
| Sep 30, 2024 | 291.73 Mn |
| Jun 30, 2024 | 294.18 Mn |
| Mar 31, 2024 | 301.39 Mn |
| Dec 31, 2023 | 314.59 Mn |
| Sep 30, 2023 | 324.55 Mn |
| Jun 30, 2023 | 333.81 Mn |
| Mar 31, 2023 | 340.80 Mn |
| Dec 31, 2022 | 341.37 Mn |
| Sep 30, 2022 | 232.71 Mn |
| Jun 30, 2022 | 226.94 Mn |
| Mar 31, 2022 | 224.92 Mn |
| Dec 31, 2021 | 234.31 Mn |
| Sep 30, 2021 | -6.90 Mn |
| Jun 30, 2021 | 15,029.00 |